Kyverna Therapeutics, Inc. (KYTX) Operating cash flow 2023–2025
Kyverna Therapeutics, Inc. (KYTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$153.7MFY2025 · since FY2023: -$52.4M → -$153.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$153.7M | -34.5% |
| FY2024 | -$114.3M | -118.0% |
| FY2023 | -$52.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KYTX financial trends
KYTX RevenueKYTX Net incomeKYTX Net marginKYTX Gross profitKYTX Gross marginKYTX Operating incomeKYTX Operating marginKYTX Free cash flowKYTX Capital expendituresKYTX Return on equityKYTX Stock buybacksKYTX Dividends paidKYTX Total assetsKYTX Total liabilitiesKYTX Shareholders’ equityKYTX overview →